Company Monitoring Page for OncoSec

latest headlines for company on cafepharma

3 Companies Developing Novel Cancer Drug Delivery Platforms
Seeking Alpha
Mon, 03/18/13 - 11:10 am
Tags:
drug delivery, cancer, Celgene, AngioDynamics, OncoSec
Stocks Could Rise For Companies Investing In Immunotherapy Treatments
Seeking Alpha
Tue, 02/19/13 - 10:12 am
Tags:
immunotherapy, Celgene, Bristol-Myers Squibb, OncoSec, ONYX Pharmaceuticals, Vical
Investments In Novel IL-12 Adminstration Platforms In The Fight Against Cancer
Seeking Alpha
Wed, 12/26/12 - 09:27 am
Tags:
Merck, OncoSec, Ziopharm, Interleukin-12
OncoSec Looking For A Rich Uncle
Seeking Alpha
Mon, 12/17/12 - 10:04 am
Tags:
OncoSec, Celsion
3 Pharmaceuticals Pursuing Non-Surgical Approaches To Combating Cancer
Seeking Alpha
Mon, 09/24/12 - 11:18 am
Tags:
OncoSec, Celsion, AngioDynamics, Bristol-Myers Squibb, cancer
3 Companies With Exciting Phase II Trial Data Close Out 2012
Seeking Alpha
Mon, 09/10/12 - 11:02 am
Tags:
Peregrine Pharmaceuticals, bavituximab, Vigabatrin, Catalyst Pharmaceutical Partners, OncoSec, NeoPulse
3 Innovative Biotech Stocks To Consider Today
Seeking Alpha
Mon, 08/13/12 - 01:36 pm
Tags:
Celgene, OncoSec, Onyx, Bayer, Arqule
3 Speculative Biotechs Worth Watching
Seeking Alpha
Sun, 07/8/12 - 01:07 pm
Tags:
OncoSec, Vical, Sangamo BioSciences
Melanoma Treatments Look To Benefit From Large Market
Seeking Alpha
Tue, 07/3/12 - 11:46 am
Tags:
Amgen, Bristol-Myers Squibb, GSK, OncoSec, Vical
Public Offerings Create Investing Opportunities In Biotech Sector
Seeking Alpha
Tue, 05/15/12 - 01:17 pm
Tags:
stock offering, Amarin, Arena Pharmaceuticals, Celldex, Horizon Pharma, NeoStem, Repros Therapeutics, Oncothyreon, OncoSec
How OncoSec Opens Up Skin Cancer Cells To Drugs
Seeking Alpha
Wed, 04/4/12 - 08:41 am
Tags:
skin cancer, OncoSec

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.